SOMATULINE Autogel 90 mg IN DUMPING SYNDROME

NCT01923649 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Dumping Syndrome

Interventions

DRUG: Lanreotide 90 mg slow release formulation
DRUG: Placebo

Sponsor

Universitaire Ziekenhuizen KU Leuven

Collaborators

[object Object]